SPECIALIZED AREAS

Non hematological malignancies

Breast Cancer

Lung Cancer

Gastrointestinal Cancer

Gynecological Cancers

Sarcomas

Hematological malignancies:

Lymphomas (Hodgkin & Non-Hodgkin)

Plasma cell neoplasms

EDUCATIONAL BACKGROUND

DNB (Medical Oncology), RGCI&RC, Rohini, India, 2017.

DNB (Internal Medicine) - Jaipur Golden Hospital, Delhi. 2005-2008.

MBBS - K.M.C, Mangalore, Karnataka, India (M.A.H.E University), 2002.

EXPERIENCES

2014 – till date – Consultant, RGCI& RC, Delhi, India,

2013-2014 - Consultant, Internal Medicine, Lifecare Hospital, Bahadurgarh, Haryana

2010-2013 - Senior Resident in Department of Cardiology, BSA Hospital, Rohini (GNCTD)

2008-2010 - Senior Resident in Department of Medicine, BMH, Pitampura (GNCTD)

2003-2004 - Worked as a House Surgeon in Neuro-surgery, P.G.I.M.S, Rohtak, Haryana.

2002-2003 - One Year Compulsory Rotating Internship K.M.C,Mangalore, Karnataka.

ABOUT

Dr Parveen Jain completed MBBS in 2002, he completed his post-graduation training in 2008. He is working in the field of Medical Oncology for more than 3 years at RGCI&RC, Delhi. He has a vast experience in the management of both hematological & non hematological malignancies (breast, lung, GI malignancies and other solid tumors). He cleared “European Certified Medical Oncologist” exam conducted by ESMO Medical Oncology in 2016.

Dr. Parveen Jain has keen interest in conducting clinical research. He is an active member of European Society for Medical Oncology (ESMO). He has done many oral and poster presentations in national conferences.

PROFESSIONAL JOURNEY

ACHIEVEMENTS & AWARDS

Awarded 2nd Prize for Oral paper presentation at RGCON 2017 titled “To evaluate role of Ki-67 index as a predictor of response to neo-adjuvant chemotherapy in breast cancer”.

Award Poster Presentation at ISMPO ISOCON 2015 titled “To analyze the Epidemiological & Molecular profile of patients with metastatic adenocarcinoma lung presenting to a single unit of a tertiary cancer centre (RGCI & RC) in North India”.

Won 2nd prize at annually held “SPEAK program”, Mumbai with a theme of Ovarian Cancer management.

Won 1st prize in “Soft tissue sarcoma quiz” at Action Cancer Institute, Delhi.

Runner up position in ICON Oncology Quiz (ICON 2017, Lucknow

PUBLICATIONS

Original Articles

Efficacy and Toxicity Profile of Maintenance Pemetrexed in Patients With Stage IV adenocarcinoma Lung in Indian Population. South Asian J Cancer 5 (4), 196-203. Oct-Dec 2016.

To Assess Efficacy of First Line TKIs in EGFR Mutant Advanced NSCLC Patients from North India: Journal of Thoracic Oncology, 2016.

Epidemiology and resistance pattern of bacterial isolates among cancer patients in a tertiary care oncology centre in North India. Indian Journal of Cancer 2016.

Letter To Editor

Sorafenib induced hand foot syndrome (Provisionally accepted in Archives of medicine and health sciences and Ahead of print)

5 FU induced flagellate rash – (Provisionally accepted in Pigment international)

Poster & Oral Presentations:

Poster Presentation at ISMPO ISOCON 2015 titled “To Analyse the Efficacy and Toxicity Profile of Continuation Maintenance Pemetrexed in Advanced NSCLC: An Indian Data”.

Research

DNB (General Medicine) thesis: To evaluate the etiologic and prognostic factors of generalized convulsive status epilepticus in patients of age more than 12 years and to evaluate the response of patients with status epilepticus to treatment protocol suggested by Epilepsy foundation of America’s working group in our subset of patient.

DNB (Medical Oncology) thesis: To evaluate the role of Ki-67 index as a predictor of response to neo-adjuvant chemotherapy in patients with breast cancer presenting at RGCIRC.